{{Rsnum
|rsid=6942930
|Chromosome=7
|position=1512784
|Orientation=plus
|GMAF=0.4541
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 21.6 | 55.0 | 23.4
| HCB | 41.0 | 47.0 | 11.9
| JPT | 49.5 | 44.0 | 6.4
| YRI | 11.1 | 61.9 | 27.0
| ASW | 21.8 | 49.1 | 29.1
| CHB | 41.0 | 47.0 | 11.9
| CHD | 42.3 | 41.3 | 16.3
| GIH | 23.5 | 52.0 | 24.5
| LWK | 24.5 | 50.0 | 25.5
| MEX | 21.8 | 61.8 | 16.4
| MKK | 30.7 | 54.7 | 14.7
| TSI | 22.8 | 54.5 | 22.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6942930
|Name_s=
|Gene_s=INTS1
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363822
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6942930
|overall_frequency_n=1568
|overall_frequency_d=3234
|overall_frequency=0.484848
|n_genomes=43
|n_genomes_annotated=0
|n_haplomes=55
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}